Biosergen AS (BIOSGN) — Cash Flow Reinvestment Rate
Latest as of June 2024:
0.33x
Biosergen AS (BIOSGN) has a Cash Flow Reinvestment Rate of 0.33x as of June 2024, reinvesting Skr4.41 Million (capex Skr0.00 plus investments Skr-4.41 Million) from operating cash flow of Skr13.45 Million. Explore BIOSGN cash generation efficiency to assess how effectively this company generates cash.
Reinvestment Rate
0.33x
(Capex + Investments) / Operating CF
Total Reinvested
Skr4.41 Million
Capex + Investments
Operating Cash Flow
Skr13.45 Million
SEK
Capital Expenditures
Skr0.00
SEK
Annual Cash Flow Reinvestment Rate for Biosergen AS (None–None)
Year-by-year capital reinvestment analysis for Biosergen AS. For live market cap and broader valuation context, see Biosergen AS (BIOSGN) total market value.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow